HK Stock Market Move | HUAYAN ROBOTICS(01021) rose nearly 15% in early trading; the company showcased its high-precision motion platform products at the CIOE Optoelectronics Expo.
HUAYAN ROBOTICS (01021) rose nearly 15% in early trading. As of press time, it was up 7.16% at HK$10.63, with a turnover of HK$34.8498 million.
HUAYAN ROBOTICS(01021) rose nearly 15% in early trading. As of press time, it was up 7.16% at HK$10.63, with a turnover of HK$34.8498 million.
On the news front, the 27th China International Optoelectronic Exposition (CIOE) was held in Shenzhen from September 9 to 11. HUAYAN ROBOTICS exhibited a range of high-precision motion platforms, with a focus on showcasing its XYZ three-axis optical coupling platform, XY motion platform, and Z-axis voice coil motor products.
During the expo, numerous upstream and downstream customers and industry experts visited the booth to engage in in-depth discussions on high-precision motion solutions and customized development, and gave positive feedback on Huayan's product performance and localization achievements. Through this exhibition, HUAYAN ROBOTICS combined its core precision motion technology with the needs of the optoelectronic industry, continuing to support the industrialization of the optoelectronic interconnect industry chain.
Related Articles
.png)
DIRECTEL (08337) temporarily suspended from September 16 pending publication of inside information

HK Stock Market Move | SBP GROUP (01177) rises nearly 3% as marketing applications for TQH2722 and TQB2102 are both accepted

Fourth attempt finally approved! Bruker Corporation Field (BAM.US) acquires Australian pipe products manufacturer RWC for $2.9 billion at a 32% premium.
DIRECTEL (08337) temporarily suspended from September 16 pending publication of inside information
.png)
HK Stock Market Move | SBP GROUP (01177) rises nearly 3% as marketing applications for TQH2722 and TQB2102 are both accepted

Fourth attempt finally approved! Bruker Corporation Field (BAM.US) acquires Australian pipe products manufacturer RWC for $2.9 billion at a 32% premium.

RECOMMEND





